Search

everythinglearnresearchcommunity

for

Search:↓

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

Cannabinoid receptor-1 signaling is essential for the survival and growth of human hair follicle stem cells.

Estrogen affects hair growth and skin cell multiplication.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Merremia peltata leaf extract, particularly the bufotalinin compound, shows potential for treating hair loss.

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

Agouti protein affects melanocortin receptors through competitive antagonism and receptor down-regulation.

Finasteride may improve prostate cancer treatment outcomes.

Using polymeric micelles to deliver spironolactone topically could improve wound healing in skin affected by glucocorticoids.

Blocking glucocorticoid receptors improves glucose metabolism in a PCOS mouse model.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

The estrogen receptor pathway controls hair growth cycles and affects skin cell growth.

Androgenetic alopecia linked to COVID-19 severity; drugs reducing androgen receptor activation may help.

CRTH2 antagonists might be useful for treating many conditions because they play a role in immune and inflammation responses.

Prolactin and TGF-β receptor blockers might help treat hair loss.

Thiazole, a sulfur and nitrogen chemical, is useful in creating potential drugs for conditions like seizures, cancer, bacterial infections, tuberculosis, inflammation, malaria, viruses, Alzheimer's, diabetes, and A1-receptor issues.

Spironolactone successfully treated hair loss in a 9-year-old girl.

New treatments for chronic central serous chorioretinopathy show promise in preventing permanent vision loss.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Steroid hormones are crucial for body functions and have various medical uses, but their misuse can lead to dependence.

Bimatoprost treats glaucoma and promotes hair growth, with potential for more medical uses.

New treatments for common hair loss might be safer and more effective than current options.

Hair loss can be treated with common methods like minoxidil and finasteride, but new potential treatments include growth factors, cytokines, and platelet-rich plasma injections.

Stress can stop hair growth in mice, and treatments can reverse this effect.

Stress can cause hair loss by negatively affecting hair follicles and this effect might be reversed with specific treatments.

Female pattern hair loss can be treated with medications, surgery, and cosmetic products, considering its psychological impact.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Prolactin affects the production of different keratins in human hair, which could lead to new treatments for skin and hair disorders.

Targeting glucocorticoid action might help treat type-2 diabetes, but human trials are needed.

Bimatoprost, a glaucoma medication, may also help treat hair loss.